NAPSRx News: Avion Pharmacueticals obtains positive feedback from the FDA on Women's Health NDA

WASHINGTON - June 17, 2014 - PRLog -- The company recently received positive feedback from the FDA for two new drug applications in the Women's Health group. Avion Pharmaceuticals CEO Mark Pugh said the company is extremely elated to receive this news from the FDA stating,"Avion continues to diligently pursue product opportunities that are targeted to improve the health and well-being of women and babies,"

"The positive news on the progress of these two NDAs will allow us to continue to work toward achieving our business goals."

Allen Fields VP and head of Research of development at Avion also added, "Avion's strategy of continuing to work with the best consultants, clinical research organizations, and manufacturers, clearly provides Research and Development the ability to support corporate goals and provide our customers with unique products."

Upon receiving this FDA feedback, the company will be moving into Phase II/III on one NDA Program, and into Phase II on the other. In line with the company's strategic corporate mission, both NDAs have projected approvals of late 2016 and early 2017.

With such industry leaders receiving positive feedback on the advancement of their therapeutic breakthroughs, they will need both certified and qualified individuals to sell their product, once approved. When industry leaders look for new candidates for entry level positions, they look toward individuals that are industry trained. Companies are looking for people that have the background to sell their product both proficiently and efficiently.

CANDIDATES WHO WANT TO BREAK INTO PHARMACEUTICAL SALES!- Upon successful completion of the training each student will receive the Certification Mark of the CNPR®. The CNPR® represents a level of industry achievement and a demonstrated knowledge of pharmacology, medical terminology, pharmaceutical selling guidelines, physician selling techniques and industry standards. Pharmaceutical sales candidates who have this training will differentiate themselves from other individuals looking for open positions. CNPR® graduates should immediately utilize the NAPSRx® Career Center to apply for pharmaceutical sales positions.

The CNPR is a federally trademarked certification you can earn by demonstrating the necessary knowledge in pharmacology, medical terminology, physiology, and regulations for selling pharmaceuticals. The CNPR examination is dedicated to increasing the professional level of NAPSR members and to developing meaningful and ethical standards fully accepted by both its members and members of the pharmaceutical community.

Individuals that are interested in becoming a Certified National Pharmaceutical Representative (CNPR) can contact the National Association of Pharmaceutical Sales Representatives(NAPSRx) for more information.

1-800-284-1060

www.napsronline.org